INCA II - Instituto Nacional de Cancer Jose Alencar Gomes da Silva

Rio de Janeiro 20220-410

0 studies enrolling now · 1 studies all time

What they study most

Advanced Melanoma

Studies at this site

• A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma — Running, not enrolling